{"filings":[{"id":304232,"accession_number":"0001493152-23-021404","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-06-15T23:59:59+00:00","items":["3.01","8.01"],"status":"ready","headline":"EUDA Health regains Nasdaq compliance on discounted share issuance; gets Aug 4 deadline for late filings","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq confirmed EUDA regained compliance with Listing Rule 5635(c) after CEO forfeited 271,867 shares to eliminate the discount on a $850,306 loan settlement.","Nasdaq accepted EUDA's plan to file overdue 10-K (FY2022) and 10-Q (Q1 2023) by August 4, 2023 to avoid potential delisting.","If EUDA fails to file by August 4, 2023, it may receive a delisting notice but can appeal to a Nasdaq Hearings Panel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304231,"accession_number":"0001493152-23-020785","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-06-09T23:59:59+00:00","items":["1.01","1.02","3.02","5.02","9.01"],"status":"ready","headline":"EUDA amends prepaid forwards, issues 1.6M shares; adjusts CEO settlement to $1.47/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Supplemental Agreement with CEO Dr. Kelvin Chen: 578,439 shares at $1.47/share to settle $850k loan; 271,867 shares forfeited.","Prepaid Forward Agreements accelerated as of June 8, 2023; each seller gets 800,000 shares (1.6M total) immediately due.","Sellers cannot sell more than 15% of daily trading volume; registration rights granted.","Alfred Lim appointed Executive Director effective June 6; resigns from Audit, Comp, and Nominating committees.","Board committees restructured; Audit Committee now Rajpal (chair), Lew, Wong."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304230,"accession_number":"0001493152-23-019182","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-05-26T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"EUDA Health issues ~3.26M shares to settle debts, convert notes, and raise $940K","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 1.62M settlement shares to extinguish $1.24M in debt and CEO claim ($850K).","Converted $700K note into 700K shares at $1.00; Tan Third Loan of $22,500 remains outstanding.","Private placement: 940K shares at $1.00 to accredited investors for $940K.","Shares issued to related parties: James Tan, CEO Kelvin Chen, and entities they control.","All shares unregistered; registration rights require filing after upcoming Form 10-K and 10-Qs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304229,"accession_number":"0001493152-23-018868","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-05-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"EUDA Health appoints Ajay Rajpal and Kong-Yew Wong as Class I directors; board committees reshuffled","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ajay Rajpal appointed Chairman of Audit Committee, member of Governance/Nominating and Compensation committees.","Kong-Yew Wong appointed to Audit, Governance/Nominating, and Compensation committees.","Rajpal is a chartered accountant (ICAEW); Wong is Group CEO at D'Mace Pty Ltd and founder of MyBeauty Advisor.","Both serve without compensation except expense reimbursement; terms until next shareholder election or removal.","Appointments fill vacancies from removal of David Capes and Leonard Chia (effective May 11 and May 14, 2023)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304228,"accession_number":"0001493152-23-018338","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-05-19T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"EUDA Health receives Nasdaq delisting notice for failure to file Q1 2023 10-Q","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received delinquency notice from Nasdaq on May 18, 2023 for not filing Q1 2023 Form 10-Q.","Previously missed FY2022 10-K; must submit compliance plan by June 5, 2023.","If plan accepted, extension to September 27, 2023 to file both 10-K and 10-Q.","Failure to regain compliance could lead to delisting of EUDA common stock and warrants.","Management says substantial part of filings completed but needs more time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304227,"accession_number":"0001493152-23-018259","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-05-19T23:59:59+00:00","items":["5.02","8.01"],"status":"ready","headline":"EUDA Health board dispute escalates; director Chia removed, dissident resolutions rejected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board removed Leonard Chee Hyong Chia as director on May 14, 2023, citing disruptive conduct.","On May 12, 2023, Capes and Chia claimed 51.56% shareholder approval to remove three directors; board deems resolutions invalid.","Capes and Associates also purported to terminate CEO Wei Wen Kelvin Chen and CFO Steven Sobak effective May 13, 2023.","Remaining board comprises Eric Lew, Alfred Lim, and Wei Wen Kelvin Chen; Eric Lew is Chairman.","No legal action filed yet; company states it will vigorously defend against any challenges."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304226,"accession_number":"0001493152-23-016243","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"EUDA Health removes director David Capes for cause; appoints Eric Lew as chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David Capes removed as director and chairman effective May 11, 2023 for failure to follow corporate formalities.","Eric Lew appointed Chairman of the Board, Audit Committee, and Corporate Governance and Nominating Committee.","Audit Committee now consists of Eric Lew (Chair), Alfred Lim, and Leonard Chia.","Compensation Committee consists of Alfred Lim (Chair), Eric Lew, and Leonard Chia."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304225,"accession_number":"0001493152-23-011709","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-04-10T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"EUDA Health receives Nasdaq delinquency notice for late 10-K filing","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq Notice received April 5, 2023 for failure to timely file FY 2022 10-K.","Company has 60 calendar days to submit a compliance plan; possible 180-day extension.","No immediate impact on trading; stock continues on Nasdaq under symbol EUDA.","Management says substantial part of 10-K completed but needs more time for finalization and audit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323874,"accession_number":"0001493152-23-007737","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-03-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"EUDA Health appoints Eric Lew to board as Class I director, filling vacancy","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Effective March 12, 2023, Lew Chern Yong (Eric) appointed to Board as Class I director.","Lew fills vacancy created by resignation of Gerald Lim.","Board determined Lew is independent under Nasdaq rules; no compensation for service.","Lew appointed to Corporate Governance and Nominating Committee and Compensation Committee.","Lew has over 25 years experience including executive roles at Wong Fong Industries and Y Ventures Group."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323873,"accession_number":"0001493152-23-006871","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-03-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Gerald Lim resigns from EUDA Health board effective March 1, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gerald Lim resigned as director and from the Audit Committee and Corporate Governance and Nominating Committee.","Resignation was not the result of any disagreement with the Company, its management, or the Board.","Effective date of resignation: March 1, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323872,"accession_number":"0001493152-23-006323","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-03-01T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"EUDA Health appoints Leonard Chia to board committees, David Capes as committee chair","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Leonard Chia appointed to Audit, Corporate Governance/Nominating, and Compensation committees.","David Capes appointed Chairman of the Corporate Governance and Nominating Committee.","Audit Committee now chaired by Capes; Compensation Committee chaired by Alfred Lim."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323871,"accession_number":"0001493152-23-005360","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-02-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"EUDA Health appoints David Capes as Chairman; Leonard Chia joins board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Thien Su Gerald Lim resigns as Chairman but remains director and on Audit/Governance committees.","David Francis Capes appointed Chairman, continuing as Audit Chair and on Governance/Compensation committees.","Chee Hyong Leonard Chia appointed Class II director to fill Kim Hing Chan's vacancy, effective Feb 15, 2023.","Mr. Chia is independent, has 30+ years legal experience, and will receive no compensation for board service.","Both resignations were not due to any disagreement with the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323870,"accession_number":"0001493152-23-003149","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2023-01-31T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"EUDA Health Board director Kim Hing Chan resigns effective Jan 25, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kim Hing Chan resigned from the Board of Directors effective January 25, 2023.","He was a member of the Compensation Committee at the time of resignation.","The resignation was not due to any disagreement with the company, management, or Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341850,"accession_number":"0001493152-22-033558","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-11-23T23:59:59+00:00","items":["1.01","2.01","5.06","9.01","4.01","3.01","3.03","5.01","5.02","5.03","5.05","8.01"],"status":"ready","headline":"EUDA Health completes business combination with 8i Acquisition 2 Corp.; now public on Nasdaq","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Business combination closed Nov 17, 2022; 8i Acquisition 2 renamed EUDA Health Holdings Limited.","Ordinary shares and warrants trade on Nasdaq under EUDA and EUDAW; prior symbols LAX, LAXXW, etc. delisted.","Watermark Developments holds 38.5% of 22.4M outstanding shares; Meng Dong (James) Tan holds 23.4%.","Lock-up agreement: Seller and designees cannot dispose of Lockup Shares for 18 months post-closing.","Auditor changed from UHY to Marcum Asia CPAs LLP effective after closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341849,"accession_number":"0001493152-22-031708","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-11-14T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"8i Acquisition 2 enters prepaid forward for up to 1.125M shares; over 7M shares tendered for redemption at $10.0837","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Prepaid Forward Agreement with Alto Opportunity Master Fund for up to 1,125,000 ordinary shares to help ensure Nasdaq listing requirements for the EUDA Health combination.","As of Nov 11, 2022, 7,091,270 shares tendered for redemption; final redemption price set at $10.0837 per share.","Business combination closing expected on or about Nov 16, 2022.","Break-up fee of $1M plus out-of-pocket expenses payable jointly by 8i and EUDA if the transaction is terminated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341848,"accession_number":"0001493152-22-031419","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"8i Acquisition 2 shareholders approve EUDA Health business combination; 8.2M shares redeemed","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All proposals approved at Nov 10 special meeting: business combination, name change to EUDA Health Holdings, stock issuance, and director election.","8,195,770 ordinary shares tendered for redemption at $10.0837 per share (~74% of outstanding shares).","Shareholders may withdraw redemption requests until 5 p.m. ET on Nov 11, 2022.","Five directors elected; effective upon consummation of the Business Combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341847,"accession_number":"0001493152-22-031193","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"8i enters prepaid forward agreement for up to 1.4M shares; 8.2M shares redeemed at ~$10.08","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Prepaid Forward Agreement with institutional investor: may purchase up to 1,400,000 shares to hold for benefit of 8i or EUDA post-close.","Prior Forward Purchase Agreement with Greentree terminated on November 9, 2022.","8,195,770 shares tendered for redemption; per-share redemption price approximately $10.08.","Purpose: to help meet Nasdaq Global Market listing requirement of $20M minimum market value of unrestricted publicly held shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341846,"accession_number":"0001493152-22-030856","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-11-07T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"8i Acquisition 2 enters forward purchase agreement with Greentree to support business combination with EUDA Health","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Forward Purchase Agreement with Greentree for up to 125,000 shares at $10.41 each, on 60th day post-closing.","Waiver Agreement waives several closing conditions, including bank consents and EUDA's minimum $10M cash requirement.","GSV Capital advisory fee reduced from 50,000 to 12,500 shares of 8i after closing.","Pro forma combined revenue $5.1M for H1 2022; net loss $864K attributable to shareholders.","Risk added: 8i will not have immediate access to escrowed funds after closing, potentially affecting liquidity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341845,"accession_number":"0001493152-22-027757","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-10-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"8i Acquisition 2 Corp. commissions research report on itself and EUDA Health Limited","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Retained Fundamental Research Corp. to prepare a research report on the Company and EUDA Health Limited.","Report furnished as Exhibit 99.1 under Regulation FD; no other material details disclosed.","Company is a SPAC; EUDA Health Limited may be a potential business combination target."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358700,"accession_number":"0001493152-22-025318","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-09-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"8i Acquisition 2 amends SPA with EUDA Health; adds dual-signature condition on bank account disbursements","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Third Amendment to Share Purchase Agreement requires two signatures for any post-closing bank account disbursement; one must be sponsor-nominated independent director.","Condition to closing: Purchaser must add sponsor-nominated person as authorized signatory to the Purchaser Bank Account (CitiBank, account 12867700).","Post-closing covenant: Until Jan 2, 2024, the company cannot change signatories or reduce number from two without sponsor consent.","Amendment executed on Sept 7, 2022, among EUDA Health, Watermark Developments, 8i Acquisition 2, and indemnified representative."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358699,"accession_number":"0001493152-22-023281","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-08-17T23:59:59+00:00","items":["2.03","9.01"],"status":"ready","headline":"8i Acquisition 2 Corp. issues $200K promissory note to CEO, convertible at $10/unit","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued unsecured promissory note for $200,000 to CEO and Chairman Tan Meng Dong (James).","Note bears no interest and matures upon closing of a business combination.","Holder may convert the note into units at $10.00 per unit, same as IPO units.","Proceeds provide working capital; note is a direct financial obligation of the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358698,"accession_number":"0001493152-22-018753","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-07-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"8i Acquisition 2 furnishes updated investor presentation for EUDA Health business combination","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Updated investor deck and executive summary filed for the proposed share purchase of EUDA Health.","No new financial terms or deal changes disclosed beyond previously announced SPA (April 11, 2022, as amended).","Specific presentation content not available in the filing; exhibits 99.1 and 99.2 are not reproduced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377482,"accession_number":"0001493152-22-016462","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-06-10T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"8i Acquisition 2 Corp. amends SPAC deal with EUDA Health; consideration cut to $140M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Initial consideration reduced to $140M, payable in LAX ordinary shares at $10.00 per share.","Earnout: up to 4M additional shares based on share price thresholds ($15/$20) or revenue/net income targets (2023: $20.1M/$3.6M; 2024: $40.1M/$10.1M).","Indemnification basket reduced from $2.5M to $636,636; seller must cover specific liabilities including unpaid receivable of SGD 5.15M.","Pro forma enterprise value of combined company estimated at $172M; EUDA Health revised projections exclude regional expansion due to COVID delays.","Second Amendment also expands seller indemnity for employment law compliance and property insurance obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377481,"accession_number":"0001493152-22-015543","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-06-01T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"8i Acquisition 2 extends due diligence for EUDA Health combination to June 15, 2022","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Parties amended the Share Purchase Agreement on May 30, 2022.","Due diligence review period extended from May 31, 2022 to June 15, 2022.","Amendment involves LAX, EUDA Health, Watermark Developments, and representative Kwong Yeow Liew.","Business combination to be effected through purchase of all EUDA Health shares by LAX."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377480,"accession_number":"0001493152-22-009698","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2022-04-12T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"LAX signs $550M SPAC merger with EUDA Health in all-stock deal","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Initial consideration of $550M in LAX shares at $10 per share; up to 9M additional earnout shares at $15, $20, $25 thresholds.","Closing conditions include LAX shareholders approval, regulatory clearances, minimum $10M EUDA cash, and $5M net tangible assets.","Seller locked up for 18 months post-close; CEO Meng Dong Tan holds 10% of Seller, a related-party interest.","Due diligence must be completed by May 31, 2022; deal target close by Nov 24, 2022 unless extended.","Joint press release issued April 12, 2022; LAX board unanimously approved and recommends shareholder approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":414725,"accession_number":"0001493152-21-031412","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2021-12-14T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"8i Acquisition 2 Corp. announces separate trading of shares, warrants, and rights starting Dec 14","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ordinary shares (LAX), warrants (LAXXW), and rights (LAXXR) begin separate trading on Nasdaq on December 14, 2021.","Units not separated continue to trade under LAXXU; holders must contact transfer agent via broker to separate.","The SPAC's IPO closed on November 22, 2021; separate trading is a standard post-IPO milestone."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":414724,"accession_number":"0001493152-21-030216","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2021-12-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"8i Acquisition 2 Corp closes IPO of 8,625,000 units at $10.00, gross proceeds $86.25M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 8,625,000 units closed Nov 24, 2021 at $10.00/unit; gross proceeds $86,250,000 including full over-allotment exercise.","Sponsor purchased 292,250 private units at $10.00 each for $2,922,500; proceeds added to trust.","$86,250,000 of net proceeds deposited into trust account for public shareholders' benefit.","Balance sheet as of Nov 24, 2021: $87.25M total assets, $864,830 cash outside trust, $85.55M ordinary shares subject to redemption, $1.8M accumulated deficit.","Company has 12 months (up to 18 with extensions) to consummate initial business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":414723,"accession_number":"0001493152-21-029838","cik":1847846,"company_name":"EUDA Health Holdings Ltd","ticker":"EUDA","form_type":"8-K","filed_at":"2021-11-24T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"8i Acquisition 2 Corp. prices $75M IPO, closes $86.25M including full over-allotment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 7.5M units at $10/unit priced Nov 22, 2021; underwriters' over-allotment of 1.125M units fully exercised.","Total gross proceeds of $86.25M from IPO and private placement deposited in trust account.","Private placement of 292,250 units at $10/unit to CEO Meng Dong (James) Tan, raising $2.9225M.","Units trade on Nasdaq under LAXXU; underlying securities to trade under LAX, LAXXW, LAXXR."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":45097396.2988272,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}